EP0472595A4 - Method of treatment of hepatitis - Google Patents

Method of treatment of hepatitis

Info

Publication number
EP0472595A4
EP0472595A4 EP19900907735 EP90907735A EP0472595A4 EP 0472595 A4 EP0472595 A4 EP 0472595A4 EP 19900907735 EP19900907735 EP 19900907735 EP 90907735 A EP90907735 A EP 90907735A EP 0472595 A4 EP0472595 A4 EP 0472595A4
Authority
EP
European Patent Office
Prior art keywords
hepatitis
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP19900907735
Other versions
EP0472595A1 (en
Inventor
Jay H. Hoofnagle
Samuel Broder
Hiroaki Mitsuya
Robert Yarchoan
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
US Department of Commerce
Original Assignee
US Department of Commerce
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by US Department of Commerce filed Critical US Department of Commerce
Publication of EP0472595A1 publication Critical patent/EP0472595A1/en
Publication of EP0472595A4 publication Critical patent/EP0472595A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
EP19900907735 1989-05-15 1990-05-15 Method of treatment of hepatitis Withdrawn EP0472595A4 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US35151989A 1989-05-15 1989-05-15
US351519 1989-05-15

Publications (2)

Publication Number Publication Date
EP0472595A1 EP0472595A1 (en) 1992-03-04
EP0472595A4 true EP0472595A4 (en) 1992-07-08

Family

ID=23381258

Family Applications (1)

Application Number Title Priority Date Filing Date
EP19900907735 Withdrawn EP0472595A4 (en) 1989-05-15 1990-05-15 Method of treatment of hepatitis

Country Status (5)

Country Link
EP (1) EP0472595A4 (en)
JP (1) JPH04501854A (en)
AU (1) AU5659990A (en)
CA (1) CA2055433A1 (en)
WO (1) WO1990014079A1 (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5039667A (en) * 1987-08-07 1991-08-13 The Governors Of The University Of Alberta Antiviral therapy for hepatitis B with 2',3'-dideoxypurine nucleosides
IL100502A (en) * 1991-01-03 1995-12-08 Iaf Biochem Int Pharmaceutical compositions containing cis-4-amino-1(hydroxymethyl-1,3-oxathiolan-5-yl)-1H-pyrimid-2-one nucleoside or its derivatives
GB9104740D0 (en) * 1991-03-06 1991-04-17 Wellcome Found Antiviral nucleoside combination
US6812233B1 (en) 1991-03-06 2004-11-02 Emory University Therapeutic nucleosides
DE4110977A1 (en) * 1991-04-05 1992-10-08 Bayer Ag SUBSTITUTED 2 ', 3'-DIDESOXY-5-TRIFLUOROMETHYLURIDINES, METHOD OF THEIR PREPARATION AND THEIR USE IN MEDICINAL PRODUCTS
GB9109506D0 (en) * 1991-05-02 1991-06-26 Wellcome Found Therapeutic nucleosides
GB9110874D0 (en) * 1991-05-20 1991-07-10 Iaf Biochem Int Medicaments
GB9226927D0 (en) * 1992-12-24 1993-02-17 Iaf Biochem Int Dideoxy nucleoside analogues

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0206497A2 (en) * 1985-05-15 1986-12-30 The Wellcome Foundation Limited Therapeutic nucleosides and their preparation
EP0216511A2 (en) * 1985-08-26 1987-04-01 THE UNITED STATES OF AMERICA as represented by the Secretary United States Department of Commerce Inhibition of in vitro infectivity and cytopathic effect of HTLV-III/LAV by 2'3'-dideoxycytidine
EP0307914A2 (en) * 1987-09-18 1989-03-22 F. Hoffmann-La Roche Ag Pharmaceutical compositions containing a dideoxynucleoside

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3817982A (en) * 1971-12-29 1974-06-18 Syntex Inc 2{40 ,3{40 -unsaturated nucleosides and method of making
US4666892A (en) * 1984-03-06 1987-05-19 Sloan-Kettering Memorial Cancer Center Method and composition for hepatitis treatment with pyrimidine nucleoside compounds
US4719235A (en) * 1984-10-16 1988-01-12 Gerald N. Kern Methods and compositions for treating viral infection
CA1327000C (en) * 1987-08-07 1994-02-15 David L.J. Tyrrell Antiviral therapy for hepatitis b

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0206497A2 (en) * 1985-05-15 1986-12-30 The Wellcome Foundation Limited Therapeutic nucleosides and their preparation
EP0216511A2 (en) * 1985-08-26 1987-04-01 THE UNITED STATES OF AMERICA as represented by the Secretary United States Department of Commerce Inhibition of in vitro infectivity and cytopathic effect of HTLV-III/LAV by 2'3'-dideoxycytidine
EP0307914A2 (en) * 1987-09-18 1989-03-22 F. Hoffmann-La Roche Ag Pharmaceutical compositions containing a dideoxynucleoside

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
ANTIVIRAL RESEARCH, vol. 12, nos 5-6, 1989, pages 301-310, Elsevier Science Publishers B.V. (Biomedical Division); B. LÖFGREN et al.: "Inhibition of RNA- and DNA-dependent duck hepatitis B virus DNA polymerase activity by nucleoside and pyrophosphate analogs" *
GASTROENTEROLOGY, vol. 94, no. 5, part 2, 1988, page A552; C. KASSIANIDES et al.: "Effects of 2',3'-dideoxycytidine in duck hepatitis B virus" *
GASTROENTEROLOGY, vol. 97, no. 5, November 1989, pages 1275-1280; C. KASSIANIDES et al.: "Inhibition of duck hepatitis B virus replication by 2',3'-dideoxycytidine" *
See also references of WO9014079A1 *
VIROLOGY, vol. 169, no. 1, March 1989, pages 213-216, Academic Press, Inc.; K. UEDA et al.: "An in vitro system for screening anti-hepatitis B virus drugs" *

Also Published As

Publication number Publication date
EP0472595A1 (en) 1992-03-04
CA2055433A1 (en) 1990-11-16
WO1990014079A1 (en) 1990-11-29
JPH04501854A (en) 1992-04-02
AU5659990A (en) 1990-12-18

Similar Documents

Publication Publication Date Title
EP0472595A4 (en) Method of treatment of hepatitis
EP0472663A4 (en) Method of treatment of hepatitis
GB8916394D0 (en) Method of treatment
GB8911258D0 (en) Method of treatment
GB8912935D0 (en) Method of treatment
GB8906426D0 (en) Method of treatment
GB8906427D0 (en) Method of treatment
GB8906428D0 (en) Method of treatment
GB8906429D0 (en) Method of treatment
GB8906430D0 (en) Method of treatment
GB8906424D0 (en) Method of treatment
GB8912934D0 (en) Method of treatment
GB8906425D0 (en) Method of treatment
GB8904258D0 (en) Method of treatment
GB8920985D0 (en) Method of treatment
GB8924155D0 (en) Method of treatment
GB8928896D0 (en) Method of treatment
GB8929033D0 (en) Method of treatment
ZA904464B (en) Method of treatment using 17beta-cyclopropylaminoandrostene
PH27228A (en) Method of treatment using 18-cyano-progesterone derivatives
GB8804204D0 (en) Method of treatment
GB8812230D0 (en) Method of treatment
GB8803008D0 (en) Method of treatment
GB8800565D0 (en) Method of treatment
GB8804206D0 (en) Method of treatment

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19911114

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH DE DK ES FR GB IT LI LU NL SE

A4 Supplementary search report drawn up and despatched

Effective date: 19920520

AK Designated contracting states

Kind code of ref document: A4

Designated state(s): AT BE CH DE DK ES FR GB IT LI LU NL SE

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 19931201